8-K: Know Labs Granted Extension to Regain NYSE American Listing Compliance

Know Labs has been granted an extension until March 27, 2026, by the NYSE American to regain compliance with listing standards.

Summary

• Know Labs received notice from the NYSE American that its plan to regain compliance with continued listing standards has been accepted.
• The company has been granted an extension until March 27, 2026, to meet the required standards.
• The company was previously notified that it did not meet the listing standards due to a stockholders deficit of $4.6 million as of June 30, 2024, and losses in the past five fiscal years.
• The NYSE American will periodically review the company's progress during the plan period.
• Failure to regain compliance by the deadline or make sufficient progress could lead to delisting proceedings.
• The company's stock will continue to be listed on the NYSE American during the extension period, subject to other listing requirements.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the company's non-compliance with listing standards and financial difficulties, although the extension provides a chance for recovery.

Positives

• The NYSE American has accepted Know Labs' plan to regain compliance.
• The company has been granted an extension until March 27, 2026, to meet the listing requirements.
• The company's stock will continue to be listed on the NYSE American during the plan period.

Negatives

• Know Labs was previously found to be non-compliant with NYSE American listing standards.
• The company had a stockholders deficit of $4.6 million as of June 30, 2024.
• The company has reported losses in the most recent five fiscal years.
• Failure to regain compliance by the deadline could result in delisting.

Risks

• There is no guarantee that Know Labs will be able to regain compliance with the NYSE American listing standards by the extension date.
• The company may not make sufficient progress consistent with its plan, which could lead to delisting.
• Developments and events occurring after the plan's acceptance could adversely affect the company's ability to regain compliance.
• The company's ability to meet other NYSE American continued listing standards is also a risk.

Future Outlook

The company intends to regain compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE American Company Guide during the plan period, but there is no guarantee of success.

Management Comments

• The company can provide no assurances that it will be able to make progress with respect to its plan that NYSE American will determine to be satisfactory.
• The company disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.

Industry Context

This announcement highlights the challenges faced by companies in maintaining listing compliance, particularly those with financial difficulties. It is not uncommon for companies to receive notices of non-compliance and seek extensions to rectify their situation.

Comparison to Industry Standards

• Many companies listed on exchanges like NYSE American face similar challenges in maintaining compliance with financial listing standards.
• Companies with consistent losses and negative equity often struggle to meet these requirements.
• The specific financial thresholds for continued listing vary, but the general principle of maintaining a minimum level of financial health is consistent across exchanges.
• Other companies in the biotech and medical device sector, especially those in the development stage, may face similar hurdles.

Stakeholder Impact

• Shareholders face the risk of delisting if the company fails to regain compliance.
• The company's employees may be affected by the uncertainty surrounding the company's future.
• Customers and suppliers may be concerned about the company's long-term viability.

Next Steps

• Know Labs will be subject to periodic reviews by the NYSE American during the plan period.
• The company must make sufficient progress to regain compliance with listing standards by March 27, 2026.

Key Dates

Keywords

NYSE American, listing standards, compliance, delisting, stockholders equity, extension, Know Labs, KNW